Tag: Muscular dystrophy

FDA committee backs approval of Sarepta Therapeutics’ SRP-9001 for DMD

businessnewstoday- May 13, 2023

Sarepta Therapeutics’ SRP-9001 (delandistrogene moxeparvovec) has received the backing of the Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) of the US Food and Drug ... Read More

PTC Therapeutics wins Russian approval for Translarna for nmDMD

pharmanewsdaily- December 6, 2020

US-based PTC Therapeutics has secured marketing approval in Russia for Translarna (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). The approval for ... Read More

Astellas Pharma to acquire US gene therapy company Audentes Therapeutics

pharmanewsdaily- December 8, 2019

Astellas acquisition of Audentes: Japanese pharma company Astellas Pharma has agreed to acquire US gene therapy company Audentes Therapeutics in an all-cash deal worth about ... Read More

What is Muscular Dystrophy and Types of Muscular Dystrophy Explained

pharmanewsdaily- April 1, 2018

DailyHealthNeeds.com brings you the basic introduction to Muscular Dystrophy in simple easy to understand language. Find out about Muscular Dystrophy causes, Muscular Dystrophy symptoms and ... Read More

Potential Duchenne Muscular Dystrophy therapy from Exonics gets $5m boost

pharmanewsdaily- February 28, 2017

US based Exonics Therapeutics has secured $5 million seed funding from CureDuchenne Ventures, a subsidiary of nonprofit DMD advocacy group, CureDuchenne to advance its therapy ... Read More

Pathological Conditions,Laboratory Tests and Clinical Procedures of Muscular System

pharmanewsdaily- December 25, 2013

Pathological conditions related to the muscular system are: Muscular dystrophy Polymyositis Muscular dystrophy: Muscular dystrophy is a group of inherited diseases characterized by progressive weakness ... Read More